ARS Pharmaceuticals, Inc. (SPRY)
SPRY Stock Price Chart
Explore ARS Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze SPRY price movements and trends.
SPRY Company Profile
Discover essential business fundamentals and corporate details for ARS Pharmaceuticals, Inc. (SPRY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Dec 2020
Employees
155.00
Website
https://ars-pharma.comCEO
Richard E. Lowenthal
Description
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.
SPRY Financial Timeline
Browse a chronological timeline of ARS Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.48, while revenue estimate is $31.33m.
Earnings released on 15 May 2026
EPS came in at -$0.61 falling short of the estimated -$0.53 by -15.09%, while revenue for the quarter reached $22.68m , beating expectations by +2.17%.
Earnings released on 9 Mar 2026
EPS came in at -$0.42 matching the estimated -$0.42, while revenue for the quarter reached $28.10m , beating expectations by +9.69%.
Earnings released on 10 Nov 2025
EPS came in at -$0.52 falling short of the estimated -$0.45 by -15.56%, while revenue for the quarter reached $32.50m , beating expectations by +27.04%.
Earnings released on 13 Aug 2025
EPS came in at -$0.46 falling short of the estimated -$0.41 by -12.20%, while revenue for the quarter reached $15.72m , missing expectations by -43.21%.
Earnings released on 14 May 2025
EPS came in at -$0.35 matching the estimated -$0.35, while revenue for the quarter reached $7.97m , missing expectations by -45.79%.
Earnings released on 20 Mar 2025
EPS came in at $0.52 surpassing the estimated -$0.04 by +1.40k%, while revenue for the quarter reached $86.58m , beating expectations by +574.41%.
Earnings released on 13 Nov 2024
EPS came in at -$0.20 falling short of the estimated -$0.18 by -11.11%, while revenue for the quarter reached $2.07m , missing expectations by -87.89%.
Earnings released on 6 Aug 2024
EPS came in at -$0.13 falling short of the estimated -$0.12 by -8.33%, while revenue for the quarter reached $500.00k , missing expectations by -50.00%.
Earnings released on 9 May 2024
EPS came in at -$0.11 matching the estimated -$0.11.
Earnings released on 21 Mar 2024
EPS came in at -$0.07 surpassing the estimated -$0.14 by +50.00%, while revenue for the quarter reached $30.00k .
Earnings released on 9 Nov 2023
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%.
Earnings released on 10 Aug 2023
EPS came in at -$0.18 falling short of the estimated -$0.17 by -5.88%, while revenue for the quarter reached $10.00k .
Earnings released on 15 May 2023
EPS came in at -$0.16 surpassing the estimated -$0.17 by +5.88%, while revenue for the quarter reached $20.00k .
Earnings released on 23 Mar 2023
EPS came in at $0.77 surpassing the estimated -$0.13 by +692.31%, while revenue for the quarter reached $1.32m , beating expectations by +1.36k%.
Earnings released on 2 Nov 2022
EPS came in at -$0.50 falling short of the estimated -$0.35 by -42.86%, while revenue for the quarter reached $189.00k .
Earnings released on 11 Aug 2022
EPS came in at -$0.55 falling short of the estimated -$0.48 by -14.58%, while revenue for the quarter reached $464.00k .
Earnings released on 12 May 2022
EPS came in at -$0.70 falling short of the estimated -$0.54 by -29.63%, while revenue for the quarter reached $663.00k .
Earnings released on 31 Mar 2022
EPS came in at -$0.67 surpassing the estimated -$0.70 by +4.29%, while revenue for the quarter reached $754.00k .
Earnings released on 10 Nov 2021
EPS came in at -$0.65 surpassing the estimated -$0.67 by +2.99%, while revenue for the quarter reached $528.00k .
Earnings released on 12 Aug 2021
EPS came in at -$0.70 falling short of the estimated -$0.53 by -32.08%, while revenue for the quarter reached $2.11m .
SPRY Stock Performance
Access detailed SPRY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
